The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats
Open accessAbstract
Because of its antibacterial activity nanosilver is one of the most commonly used nanomaterials. It is increasingly used in a variety of both medical and consumer products resulting in an increase in human exposure. However, the knowledge on the systemic toxicity of nanosilver is relatively limited. To determine the potential systemic toxicity of silver nanoparticles (Ag-NP) with different sizes (20 nm and 100 nm) a 28-days repeated dose toxicity study was performed in rats using intravenous administration. The toxic effect of the 20 nm Ag-NP was performed using the bench mark dose (BMD) approach. Treatment with a maximum dose of 6 mg/kg body weight was well tolerated by the animals. However, both for 20 nm and 100 nm Ag-NP growth retardation was observed during the treatment. A severe increase in spleen size and weight was present which was due to an increased cell number. Both T and B cell populations showed an increase in absolute cell number, whereas the relative cell numbers remained constant. At histopathological evaluation brown and black pigment indicating Ag-NP accumulation was noted in spleen, liver, and lymph nodes. Ag-NP was also detected incidentally in other organs. Clinical chemistry indicated liver damage (increased alkaline phosphatase, alanine transaminase, and aspartate transaminase) that could not be confirmed by histopathology. Hematology showed a decrease in several red blood cell parameters. The most striking toxic effect was the almost complete suppression of the natural killer (NK) cell activity in the spleen at high doses. Other immune parameters affected were: decreased interferon-γ and interleukin (IL)-10 production by concanavalin-A stimulated spleen cells, increased IL-1β and decreased IL-6, IL-10 and TNF-α production by lipopolysaccharide stimulated spleen cells, increase in serum IgM and IgE, and increase in blood neutrophilic granulocytes. For the spleen weight a critical effect dose of 0.37 mg/kg body weight (b.w.) could be established. The lowest critical effect dose (CED) for a 5% change compared to control animals was observed for thymus weight (CED05 0.01 mg/kg b.w.) and for functional immune parameters, i.e. decrease in NK cell activity (CED05 0.06 mg/kg b.w.) and LPS stimulation of spleen cells (CED05 0.04 mg/kg b.w.). These results show that for nanosilver the most sensitive parameters for potential adverse responses were effects on the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silver nanoparticles as a new generation of antimicrobials
Rai, M., Yadav, A., & Gade, A. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.09.002 · Cited by 6,173
Nanosilver: A nanoproduct in medical application
Chen, X., & Schluesener, H. J. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2007.10.004 · Cited by 1,888
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
De Jong, W. H., Hagens, W. I., Krystek, P., Burger, M. C., Sips, A. J. A. M., & Geertsma, R. E. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.037 · Cited by 1,615
Self-citationWijnhoven, S. W. P., Peijnenburg, W. J. G. M., Herberts, C. A., Hagens, W. I., Oomen, A. G., Heugens, E. H. W., Roszek, B., Bisschops, J., Gosens, I., Van De Meent, D., et al. (2009) · Nanotoxicology · doi:10.1080/17435390902725914 · Cited by 1,321
Self-citationPark, M. V. D. Z., Neigh, A. M., Vermeulen, J. P., de la Fonteyne, L. J. J., Verharen, H. W., Briedé, J. J., van Loveren, H., & de Jong, W. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.085 · Cited by 1,004
Self-citationKim, Y. S., Kim, J. S., Cho, H. S., Rha, D. S., Kim, J. M., Park, J. D., Choi, B. S., Lim, R., Chang, H. K., Chung, Y. H., et al. (2008) · Inhalation Toxicology · doi:10.1080/08958370701874663 · Cited by 878
Toxicity of silver nanoparticles—Nanoparticle or silver ion?
Beer, C., Foldbjerg, R., Hayashi, Y., Sutherland, D. S., & Autrup, H. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2011.11.002 · Cited by 784
van der Zande, M., Vandebriel, R. J., Van Doren, E., Kramer, E., Herrera Rivera, Z., Serrano-Rojero, C. S., Gremmer, E. R., Mast, J., Peters, R. J. B., Hollman, P. C. H., et al. (2012) · ACS Nano · doi:10.1021/nn302649p · Cited by 707
Self-citationPark, E.-J., Bae, E., Yi, J., Kim, Y., Choi, K., Lee, S. H., Yoon, J., Lee, B. C., & Park, K. (2010) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2010.05.004 · Cited by 570
The kinetics of the tissue distribution of silver nanoparticles of different sizes
Lankveld, D. P. K., Oomen, A. G., Krystek, P., Neigh, A., Troost – de Jong, A., Noorlander, C. W., Van Eijkeren, J. C. H., Geertsma, R. E., & De Jong, W. H. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.045 · Cited by 512
Self-citationSubchronic Inhalation Toxicity of Silver Nanoparticles
Sung, J. H., Ji, J. H., Park, J. D., Yoon, J. U., Kim, D. S., Jeon, K. S., Song, M. Y., Jeong, J., Han, B. S., Han, J. H., et al. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn246 · Cited by 505
Stensberg, M. C., Wei, Q., McLamore, E. S., Porterfield, D. M., Wei, A., & Sepúlveda, M. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.78 · Cited by 491
Twenty-Eight-Day Inhalation Toxicity Study of Silver Nanoparticles in Sprague-Dawley Rats
Ji, J. H., Jung, J. H., Kim, S. S., Yoon, J.-U., Park, J. D., Choi, B. S., Chung, Y. H., Kwon, I. H., Jeong, J., Han, B. S., et al. (2007) · Inhalation Toxicology · doi:10.1080/08958370701432108 · Cited by 447
Dose-Response Modeling of Continuous Endpoints
Slob, W. (2002) · Toxicological Sciences · doi:10.1093/toxsci/66.2.298 · Cited by 407
Slob, W., & Pieters, M. N. (1998) · Risk Analysis · doi:10.1023/b:rian.0000005924.18154.60 · Cited by 188
Lankveld, D. P., Rayavarapu, R. G., Krystek, P., Oomen, A. G., Verharen, H. W., van Leeuwen, T. G., De Jong, W. H., & Manohar, S. (2011) · Nanomedicine · doi:10.2217/nnm.10.122 · Cited by 160
Self-citationNano-silver – feasibility and challenges for human health risk assessment based on open literature
Christensen, F. M., Johnston, H. J., Stone, V., Aitken, R. J., Hankin, S., Peters, S., & Aschberger, K. (2010) · Nanotoxicology · doi:10.3109/17435391003690549 · Cited by 145
Nano-TiO2– feasibility and challenges for human health risk assessment based on open literature
Christensen, F. M., Johnston, H. J., Stone, V., Aitken, R. J., Hankin, S., Peters, S., & Aschberger, K. (2011) · Nanotoxicology · doi:10.3109/17435390.2010.504899 · Cited by 141
Nanotechnology in medical applications:state-of-the-art in materials and devices
Roszek, B., de, J. W., & Re, G. (2005) · Rivm Repository (Netherlands National Institute for Public Health and the Environment) · Cited by 84
Exposure to nanomaterials in consumer products
Swp, W., Dekkers, S., Wi, H., & de Jong, W. (2009) · Rivm Repository (Netherlands National Institute for Public Health and the Environment) · Cited by 49
Tonk, E. C. M., de Groot, D. M. G., Penninks, A., Waalkens-Berendsen, I. D. H., Wolterbeek, A. P. M., Slob, W., Piersma, A. H., & Loveren, H. V. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq223 · Cited by 41
Cited by
Targeting microbial biofilms: current and prospective therapeutic strategies
Koo, H., Allan, R. N., Howlin, R. P., Stoodley, P., & Hall-Stoodley, L. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.99 · Cited by 1,800
Silver nanoparticles: Synthesis, medical applications and biosafety
Xu, L., Wang, Y.-Y., Huang, J., Chen, C.-Y., Wang, Z.-X., & Xie, H. (2020) · Theranostics · doi:10.7150/thno.45413 · Cited by 1,315
Ferdous, Z., & Nemmar, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072375 · Cited by 1,019
Silver nanoparticles: synthesis, properties, and therapeutic applications
Wei, L., Lu, J., Xu, H., Patel, A., Chen, Z.-S., & Chen, G. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.014 · Cited by 970
Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes
Rudramurthy, G., Swamy, M., Sinniah, U., & Ghasemzadeh, A. (2016) · Molecules · doi:10.3390/molecules21070836 · Cited by 556
Metadata
- Authors
- De Jong, W. H., Van Der Ven, L. T. M., Sleijffers, A., Park, M. V. D. Z., Jansen, E. H. J. M., Van Loveren, H., & Vandebriel, R. J.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 34
- Issue
- 33
- Pages
- 8333-8343
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2093324608
- Cited by
- 284
- References
- 21
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.